ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Specialist

Top Specialist Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL SILVERMAN MD

Specialist

1,921

$150K

188
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$78
Average prescription price

Avg: $100

AHMED KAFAJI M.D.

Specialist

1,920

$227K

195
95 are 65+

45%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 30%

$118
Average prescription price

Avg: $100

JEROME HANTMAN MD

Specialist

1,907

$194K

179
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 30%

$102
Average prescription price

Avg: $100

MARTHA PIERCE M.D.

Specialist

1,880

$121K

170
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$64
Average prescription price

Avg: $100

PAUL TARANTINO M.D.

Specialist

1,834

$112K

404
368 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 30%

$61
Average prescription price

Avg: $100

MICHAEL SYLVA M.D.

Specialist

1,834

$169K

101
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$92
Average prescription price

Avg: $100

TIMOTHY SHANAHAN D.O.

Specialist

1,805

$88.5K

205
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 30%

$49
Average prescription price

Avg: $100

PETER LAPINSKY M.D.

Specialist

1,789

$148K

427
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 30%

$83
Average prescription price

Avg: $100

ABRAHAM GENUT MD

Specialist

1,771

$370K

281
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 30%

$209
Average prescription price

Avg: $100

AYIM AKYEA DJAMSON MD FACC

Specialist

1,769

$99.9K

136
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$57
Average prescription price

Avg: $100

JOHN CHRISTIE M.D.

Specialist

1,762

$110K

136
92 are 65+

24%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 30%

$63
Average prescription price

Avg: $100

DONNA BOOTH M.D.

Specialist

1,741

$178K

423
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 30%

$102
Average prescription price

Avg: $100

ROBERT RICKETTS M.D.

Specialist

1,721

$148K

247
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 30%

$86
Average prescription price

Avg: $100

FARHAD NASEH MD

Specialist

1,716

$180K

346
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

67%
prescriptions for brand name drugs

Avg: 30%

$105
Average prescription price

Avg: $100

JAMES MORGAN M.D., PH.D.

Specialist

1,712

$338K

226
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 30%

$198
Average prescription price

Avg: $100

ALYSSA HEIDERMAN CRNP

Specialist

1,711

$177K

278
127 are 65+

70%
patients receiving schedule two controlled substances

Avg: 9%

21%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$104
Average prescription price

Avg: $100

ZINON PAPPAS M.D.

Specialist

1,702

$322K

122
57 are 65+

63%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 30%

$189
Average prescription price

Avg: $100

HARIKISAN HEDA M.D.

Specialist

1,690

$83.5K

214
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 30%

$49
Average prescription price

Avg: $100

IMTIAZ CHOWDHRY M.D.

Specialist

1,681

$156K

209
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 30%

$93
Average prescription price

Avg: $100

HARRY KERASIDIS M.D.

Specialist

1,677

$344K

157
65 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 30%

$205
Average prescription price

Avg: $100

FRANCIS LEE M.D.

Specialist

1,665

$277K

206
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 30%

$167
Average prescription price

Avg: $100

WUN KANG M.D.

Specialist

1,658

$70.1K

77
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 30%

$42
Average prescription price

Avg: $100

NARAYAN SAHETA M.D.

Specialist

1,641

$53.4K

178
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 30%

$33
Average prescription price

Avg: $100

RUTH HOROWITZ M.D.

Specialist

1,627

$262K

199
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 30%

$161
Average prescription price

Avg: $100

LUIS ZUNIGA M.D.

Specialist

1,620

$127K

132
104 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 30%

$78
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank